With over a decade of experience, NeoGenomics delivers high-quality FISH and Cytogenetics services designed to meet the needs of biopharma partners. Our expert scientific team supports every stage of development, including assay design, validation, troubleshooting and sample processing across a wide range of hematologic malignancies and solid tumors.
From clinically validated tests to customized solutions, flexible workflow and scalable support is available to meet projects of any scope or complexity.
We specialize in the custom development and validation of novel and emerging biomarkers, ensuring our assays evolve alongside your program’s needs.
Our FISH service enables the detection of genetic aberrations such as multiploidy, translocations, amplifications or deletions across a wide variety of sample types such as FFPE (including TMA's), blood and bone marrow.
Plasma cell enrichment is available for plasma cell disorders.
Explore our webinars, white papers, and other valuable resources
